Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)
Public ClinicalTrials.gov record NCT00071487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, and Efficacy of LymphoStat-B™ Antibody (Monoclonal Anti-BLyS Antibody) in Subjects With Systemic Lupus Erythematosus (SLE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of 3 different doses of belimumab, administered in addition to standard therapy, in patients with active SLE disease.
Study identification
- NCT ID
- NCT00071487
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 449 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Belimumab 1 mg/kg Drug
- Belimumab 4 mg/kg Drug
- Belimumab 10 mg/kg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2003
- Primary completion
- Jul 31, 2005
- Completion
- May 31, 2006
- Last update posted
- Aug 6, 2013
2003 – 2006
United States locations
- U.S. sites
- 60
- U.S. states
- 28
- U.S. cities
- 55
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294-0006 | — |
| Arizona Arthritis Research | Paradise Valley | Arizona | 85253 | — |
| University of Arizona | Tucson | Arizona | 85724 | — |
| Scripps Clinic | La Jolla | California | 92037 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Stanford University School of Medicine | Palo Alto | California | 94304 | — |
| Boling Clinical Trials | Rancho Cucamonga | California | 91730 | — |
| UCDMC | Sacramento | California | 95817-1418 | — |
| Arthritis Care Center, Inc. | San Jose | California | 95126-1650 | — |
| Arthritis Associates & Osteoporosis Center Of Colorado Springs | Colorado Springs | Colorado | 80910 | — |
| Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Arthritis and Rheumatic Disease Specialties | Aventura | Florida | 33180 | — |
| Rheumatology Associates of Central Florida | Orlando | Florida | 32806 | — |
| Tampa Medical Group, P.A. | Tampa | Florida | 33614 | — |
| Emory University | Atlanta | Georgia | 30303 | — |
| Radiant Research Boise | Boise | Idaho | 83704 | — |
| Institute of Arthritis and Research | Idaho Falls | Idaho | 83404 | — |
| Northwestern University Medical School | Chicago | Illinois | 60611 | — |
| Rheumatology Associates | Chicago | Illinois | 60612 | — |
| Medical Specialists | Munster | Indiana | 46321 | — |
| Kentuckiana Center for Better Bone and Joint Health | Louisville | Kentucky | 40202 | — |
| Ochsner Clinic Foundation | Baton Rouge | Louisiana | 70809 | — |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 | — |
| The Osteoporosis and Arthritis Clinical Trial Center | Cumberland | Maryland | 21502 | — |
| Center for Rheumatology and Bone Research | Wheaton | Maryland | 20902 | — |
| Tufts--New England Medical Center | Boston | Massachusetts | 02111 | — |
| The University of Michigan Health System | Ann Arbor | Michigan | 48109-0358 | — |
| Washington University in St. Louis | St Louis | Missouri | 63110 | — |
| Arthritis Center of Nebraska | Lincoln | Nebraska | 68506 | — |
| Arthritis and Osteoporosis Center | Concord | New Hampshire | 03301 | — |
| Strafford Medical Associates, P.A. | Dover | New Hampshire | 03820 | — |
| The Center for Rheumatology | Albany | New York | 12206 | — |
| SUNY-Downstate Medical Center | Brooklyn | New York | 11203 | — |
| North Shore University Hospital | Manhasset | New York | 11030 | — |
| Aair Research | Rochester | New York | 14618 | — |
| Jacobi Medical Center | The Bronx | New York | 10461 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599-7280 | — |
| Arthritis Clinic and Carolina Bone and Joint | Charlotte | North Carolina | 28210 | — |
| Wake Forest University School of Medicine | Winston-Salem | North Carolina | 27157 | — |
| Stat Research Inc. | Dayton | Ohio | 45402 | — |
| Bone and Joint Hospital | Oklahoma City | Oklahoma | 73103 | — |
| Oklahoma Medical Research Foundation | Oklahoma City | Oklahoma | 73104 | — |
| Oklahoma Center For Arthritis Therapy & Research | Tulsa | Oklahoma | 74114 | — |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
| University of Pittsburgh School of Medicine & ASPH | Pittsburgh | Pennsylvania | 15261 | — |
| Rheumatic Disease Associates | Willow Grove | Pennsylvania | 19090 | — |
| Research Associates of North Texas | Dallas | Texas | 75246 | — |
| UT Southwestern Medical Center at Dallas | Dallas | Texas | 75390-8884 | — |
| Texas Research Center | Sugar Land | Texas | 77479 | — |
| Arthritis and Rheumatic Disease Clinic | Ogden | Utah | 84044 | — |
| Physicians Research Options, LC | Sandy City | Utah | 84070 | — |
| Arthritis Clinic of Northern Virginia, P.C. | Arlington | Virginia | 22205 | — |
| Edmonds Rheumatology Associates | Edmonds | Washington | 98026-8047 | — |
| Arthritis Northwest Rheumatology | Spokane | Washington | 99204 | — |
| Gundersen Clinic, Ltd. | La Crosse | Wisconsin | 54610 | — |
| The Medical College of Wisconsin , Inc | Milwaukee | Wisconsin | 53226 | — |
| Marshfield Medical Research Foundation | Wausau | Wisconsin | 54401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
Recently updated Lupus Erythematosus, Systemic trials
Other public records listing Lupus Erythematosus, Systemic. Sorted by last update posted; newest first. Not a recommendation.
- NCT05693571: Engagement in CHildhood-Onset Systemic Lupus Active, not recruiting
- NCT07201129: A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment Recruiting
- NCT05672576: A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus Active, not recruiting
- NCT06925542: A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease Recruiting
- NCT03543839: Trial of Belimumab in Early Lupus Recruiting
- NCT06581198: A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00071487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 6, 2013 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00071487 live on ClinicalTrials.gov.